Veru Inc

VERU · NASDAQ · Healthcare / Biotechnology

2.09USD-0.03 (-1.42%)

Price History

Full chart

Market Stats

Previous Close2.12

Open2.15

Day Range2.08 – 2.15

52-Week Range2.05 – 4.59

Volume90.53K

Market Cap43.31M

P/E (TTM)0.00

Forward P/E117.65

EPS-0.61

Dividend Yield0.00%

Beta-1.16

50-Day Avg2.49

200-Day Avg2.49

About

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.

Company Details

SectorHealthcare
IndustryBiotechnology
CEODr. Mitchell S. Steiner F.A.C.S., M.D.
Employees20
Headquarters2916 North Miami Avenue, Miami, FL, United States, 33127, USA
Websitehttps://verupharma.com

Leadership

Dr. Mitchell S. Steiner F.A.C.S., M.D.Chairman, President & CEO · b. 1961
Dr. Harry D. Fisch F.A.C.S., M.D.Vice Chairman & Chief Corporate Officer · b. 1959
Dr. K. Gary Barnette Ph.D.Chief Scientific Officer · b. 1968
Ms. Michele Greco CPACFO & Chief Administrative Officer · b. 1959
Mr. Samuel FischExecutive Director of Investor Relations & Corporate Communications
Mr. Philip R. Greenberg J.D.Executive VP, General Counsel & Secretary
Mr. Kevin J. Gilbert CPA, J.D.Executive Vice President of Corporate Development
Mr. Martin TaylerExecutive Vice President of FC2 Global Operations · b. 1969
Dr. Domingo Rodriguez M.D.Executive Vice President of Global Clinical Operations · b. 1962
Dr. Gary Bird Ph.D.Executive Vice President of Quality & Regulatory Affairs

Financials

Income Statement

Currency: USD	1990-09-30	1991-09-30	1992-09-30	1993-09-30	1994-09-30	1995-09-30	1996-09-30	1997-09-30	1998-09-30	1999-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30

Currency: USD	1990-09-30	1991-09-30	1992-09-30	1993-09-30	1994-09-30	1995-09-30	1996-09-30	1997-09-30	1998-09-30	1999-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Revenue	10.70M	13.10M	11.20M	12.50M	16.20M	2.20M	2.06M	2.92M	5.45M	4.72M	5.77M	6.72M	8.42M	9.05M	8.83M	11.16M	14.82M	19.32M	25.63M	27.54M	22.22M	18.57M	35.03M	31.46M	24.49M	32.60M	22.13M	13.66M	15.86M	31.80M	42.59M	61.26M	39.35M	16.30M	16.89M	0
Growth (%)	-	+22.43%	-14.50%	+11.61%	+29.60%	-86.42%	-6.17%	+41.28%	+86.92%	-13.50%	+22.30%	+16.46%	+25.32%	+7.47%	-2.39%	+26.42%	+32.82%	+30.33%	+32.68%	+7.45%	-19.32%	-16.46%	+88.71%	-10.21%	-22.15%	+33.13%	-32.13%	-38.29%	+16.18%	+100.47%	+33.92%	+43.83%	-35.76%	-58.59%	+3.62%	-100.00%
Cost of Revenue	6.10M	7.20M	6.10M	6.90M	7.50M	2.50M	3.68M	3.48M	5.27M	3.31M	3.60M	5.34M	4.86M	5.46M	5.21M	6.37M	9.33M	12.16M	14.90M	14.03M	9.30M	8.70M	14.41M	13.95M	11.37M	13.63M	8.78M	6.64M	7.08M	10.15M	11.81M	13.33M	8.76M	8.73M	11.03M	152.10K
Gross Profit	4.60M	5.90M	5.10M	5.60M	8.70M	-300.00K	-1.62M	-559.30K	178.03K	1.40M	2.16M	1.38M	3.56M	3.59M	3.62M	4.79M	5.49M	7.16M	10.73M	13.52M	12.92M	9.87M	20.62M	17.50M	13.12M	18.97M	13.35M	7.02M	8.78M	21.66M	30.79M	47.93M	30.59M	7.57M	5.85M	-152.10K
Gross Margin	42.99%	45.04%	45.54%	44.80%	53.70%	-13.64%	-78.50%	-19.18%	3.27%	29.70%	37.49%	20.52%	42.31%	39.67%	41.03%	42.93%	37.03%	37.04%	41.86%	49.08%	58.16%	53.14%	58.86%	55.65%	53.58%	58.18%	60.33%	51.40%	55.36%	68.10%	72.28%	78.24%	77.73%	46.43%	34.67%	-
Operating Expense	3.70M	7.30M	3.80M	7.70M	10.40M	7.90M	6.33M	4.68M	3.33M	4.43M	4.80M	1.98M	6.23M	4.92M	4.69M	6.10M	5.25M	6.28M	7.55M	8.80M	8.58M	6.57M	9.68M	7.71M	9.20M	12.35M	10.33M	15.51M	29.65M	28.09M	45.53M	34.95M	113.81M	101.35M	42.77M	24.60M
Operating Income	900.00K	-1.40M	1.30M	-2.10M	-1.70M	-8.20M	-7.95M	-5.24M	-3.15M	-3.03M	-2.64M	-602.86K	-2.67M	-1.34M	-1.07M	-1.31M	240.35K	875.91K	3.18M	4.72M	4.35M	3.30M	10.94M	9.79M	3.92M	6.62M	3.02M	-8.49M	-20.87M	-6.44M	-14.75M	12.97M	-83.22M	-93.78M	-36.92M	-24.75M
Operating Margin	8.41%	-10.69%	11.61%	-16.80%	-10.49%	-372.73%	-385.12%	-179.62%	-57.80%	-64.17%	-45.75%	-8.98%	-31.72%	-14.76%	-12.09%	-11.75%	1.62%	4.53%	12.42%	17.13%	19.57%	17.75%	31.23%	31.12%	16.02%	20.30%	13.64%	-62.20%	-131.57%	-20.24%	-34.62%	21.18%	-211.47%	-575.46%	-218.61%	-
EBITDA	800.00K	-1.60M	-1.10M	-2.50M	-2.20M	-8.30M	-7.10M	-4.76M	-2.73M	-1.74M	-812.89K	321.06K	-1.66M	210.53K	19.17K	-1.11M	573.99K	1.01M	3.40M	5.32M	4.69M	3.76M	11.40M	10.35M	4.51M	7.11M	4.92M	-8.12M	-20.42M	-5.96M	-14.28M	9.33M	-83.01M	-89.98M	-36.20M	-35.38M
EBITDA Margin	7.48%	-12.21%	-9.82%	-20.00%	-13.58%	-377.27%	-343.95%	-163.37%	-50.15%	-36.95%	-14.10%	4.78%	-19.70%	2.33%	0.22%	-9.93%	3.87%	5.23%	13.27%	19.31%	21.11%	20.25%	32.54%	32.89%	18.43%	21.81%	22.25%	-59.47%	-128.72%	-18.75%	-33.54%	15.23%	-210.94%	-552.10%	-214.38%	-
Net Income	300.00K	-1.50M	-4.30M	-3.70M	-3.00M	-8.30M	-8.66M	-5.61M	-3.36M	-3.75M	-3.69M	-1.17M	-3.48M	-2.37M	-2.02M	-1.36M	282.03K	1.69M	4.97M	6.54M	6.74M	5.40M	15.30M	14.34M	2.43M	4.35M	344.73K	-6.61M	-23.94M	-12.02M	-18.97M	7.39M	-83.78M	-93.15M	-37.80M	-22.73M
Net Income Margin	2.80%	-11.45%	-38.39%	-29.60%	-18.52%	-377.27%	-419.54%	-192.33%	-61.59%	-79.53%	-63.99%	-17.44%	-41.36%	-26.20%	-22.87%	-12.15%	1.90%	8.77%	19.38%	23.73%	30.32%	29.08%	43.67%	45.59%	9.93%	13.33%	1.56%	-48.42%	-150.89%	-37.79%	-44.55%	12.07%	-212.88%	-571.60%	-223.86%	-
R&D	-	-	-	-	-	-	361.09K	-	-	-	67.00K	-	-	60.00K	179.20K	273.78K	210.88K	208.61K	284.22K	105.92K	381	10.93K	5.28K	4.75K	5.58K	219.81K	99.39K	3.50M	10.85M	13.74M	16.94M	32.69M	70.65M	51.20M	12.81M	15.59M
R&D as % of Total Revenue	-	-	-	-	-	-	17.49%	-	-	-	1.16%	-	-	0.66%	2.03%	2.45%	1.42%	1.08%	1.11%	0.38%	0.00%	0.06%	0.02%	0.02%	0.02%	0.67%	0.45%	25.66%	68.40%	43.21%	39.76%	53.37%	179.51%	314.18%	75.85%	-
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	74.91K	2.09M	2.39M	3.98M	124.63K	296.18K	42.97K	50.56K	127.12K	3.32M	2.04M	2.95M	4.71M	4.62M	4.85M	4.37M	2.43M	607.47K	-
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.39%	8.16%	8.66%	17.93%	0.67%	0.85%	0.14%	0.21%	0.39%	14.99%	14.95%	18.60%	14.80%	10.85%	7.92%	11.10%	14.89%	3.60%	-

Balance Sheet

Currency: USD	1990-09-30	1991-09-30	1992-09-30	1993-09-30	1994-09-30	1995-09-30	1996-09-30	1997-09-30	1998-09-30	1999-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30

Currency: USD	1990-09-30	1991-09-30	1992-09-30	1993-09-30	1994-09-30	1995-09-30	1996-09-30	1997-09-30	1998-09-30	1999-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Assets	9.20M	8.20M	10.10M	10.10M	18.60M	13.80M	13.74M	8.34M	7.56M	6.51M	4.12M	4.33M	5.56M	5.04M	4.50M	5.68M	7.45M	11.19M	13.83M	18.54M	18.37M	19.44M	30.45M	35.17M	31.67M	37.47M	38.62M	55.31M	48.45M	53.63M	51.54M	178.15M	135.36M	50.02M	60.42M	29.84M
Total Liabilities	3.00M	3.50M	4.60M	5.80M	5.90M	6.20M	6.19M	4.78M	4.62M	4.78M	4.81M	4.28M	4.93M	4.54M	2.67M	2.37M	2.67M	3.75M	4.12M	5.59M	2.24M	2.69M	6.23M	3.77M	3.61M	4.34M	4.69M	6.85M	18.97M	21.30M	21.43M	25.85M	52.56M	30.34M	28.10M	11.50M
Total Equity	6.20M	4.70M	5.50M	4.30M	12.70M	7.60M	7.55M	3.55M	2.93M	1.72M	-693.07K	52.32K	630.28K	493.13K	1.83M	3.31M	4.77M	7.45M	9.71M	12.95M	16.13M	16.75M	24.22M	31.40M	28.07M	33.13M	33.93M	48.45M	29.48M	32.33M	30.11M	152.29M	82.80M	19.68M	32.32M	18.33M
Cash	4.60M	1.50M	100.00K	-	3.50M	1.50M	1.52M	1.63M	1.48M	570.71K	457.12K	469.41K	558.64K	632.29K	755.48K	1.78M	1.83M	799.42K	1.92M	2.81M	2.92M	4.31M	5.29M	8.92M	5.80M	4.11M	2.39M	3.28M	3.76M	6.30M	13.59M	122.36M	80.19M	9.63M	24.92M	15.79M
Total Debt	1.20M	700.00K	3.20M	1.90M	1.80M	200.00K	255.22K	582.97K	630.95K	2.00M	2.61M	2.05M	2.31M	2.28M	475.30K	560.00K	-	-	49.60K	34.43K	13.00K	-	-	-	-	-	-	-	11.15M	12.12M	14.14M	13.74M	15.88M	14.41M	13.86M	3.12M
Net Debt	-3.40M	-800.00K	3.10M	1.90M	-1.70M	-1.30M	-1.27M	-1.05M	-849.34K	1.43M	2.15M	1.58M	1.75M	1.65M	-280.18K	-1.22M	-1.83M	-799.42K	-1.87M	-2.78M	-2.91M	-4.31M	-5.29M	-8.92M	-5.80M	-4.11M	-2.39M	-3.28M	7.39M	5.82M	547.57K	-108.62M	-64.31M	4.78M	-11.05M	-12.68M

Cash Flow

Currency: USD	1990-09-30	1991-09-30	1992-09-30	1993-09-30	1994-09-30	1995-09-30	1996-09-30	1997-09-30	1998-09-30	1999-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30

Currency: USD	1990-09-30	1991-09-30	1992-09-30	1993-09-30	1994-09-30	1995-09-30	1996-09-30	1997-09-30	1998-09-30	1999-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Operating Cash Flow	300.00K	-1.10M	-2.00M	200.00K	-7.70M	-4.60M	-4.07M	-5.61M	-2.75M	-2.84M	-1.03M	-625.02K	-378.65K	290.01K	-216.76K	-199.26K	267.94K	-42.05K	4.24M	5.75M	3.99M	6.97M	10.36M	11.79M	3.67M	-1.55M	-1.71M	982.89K	-11.55M	-5.49M	-1.93M	-15.57M	-47.51M	-88.01M	-21.68M	-30.04M
Investing Cash Flow	-200.00K	-1.10M	-600.00K	-400.00K	-500.00K	-500.00K	-486.23K	3.20M	782.03K	-22.64K	-11.28K	-172.79K	-33.90K	51.34K	116.09K	-224.63K	-361.93K	-852.66K	-459.18K	-1.50M	49.36K	-46.23K	-654.33K	-302.20K	-97.31K	-135.42K	-6.37K	-90.37K	-50.65K	-108.52K	-105.76K	14.62M	4.27M	6.33M	146.21K	25.14M
Financing Cash Flow	4.40M	-800.00K	1.20M	200.00K	11.70M	3.10M	5.96M	574.58K	1.79M	1.92M	891.85K	842.81K	498.78K	-129.38K	121.82K	1.52M	-13.80K	-278.27K	-1.88M	-3.24M	-3.93M	-5.59M	-8.66M	-7.86M	-6.69M	-6.29K	12.08M	12.08M	12.08M	8.13M	9.33M	109.72M	1.07M	11.11M	36.83M	-4.22M
Capital Expenditure	100.00K	800.00K	300.00K	100.00K	200.00K	0	596.40K	24.60K	58.83K	0	11.28K	57.79K	35.01K	47.23K	43.99K	251.69K	124.19K	1.02M	347.60K	1.64M	51.13K	46.29K	718.30K	302.20K	97.31K	135.42K	6.37K	133.49K	50.65K	108.52K	105.76K	376.65K	733.05K	665.70K	158.32K	1.08K
Free Cash Flow	200.00K	-1.90M	-2.30M	100.00K	-7.90M	-4.60M	-4.67M	-5.63M	-2.81M	-2.84M	-1.04M	-682.81K	-413.66K	242.78K	-260.75K	-450.94K	143.75K	-1.06M	3.90M	4.10M	3.94M	6.92M	9.64M	11.49M	3.57M	-1.68M	-1.72M	849.40K	-11.60M	-5.59M	-2.04M	-15.95M	-48.24M	-88.68M	-21.84M	-30.04M
Dividends Paid	-	-	-	-	100.00K	-	-	-	-	161.67K	40.15K	107.19K	95.83K	104.40K	11.20K	7.21K	15.20K	7.20K	165.46K	104.78K	4.12M	5.55M	6.19M	7.47M	6.07M	5.34K	0	0	10.07M	-	13.82M	-	-	-	-	-
FCF to OCF	66.67%	172.73%	115.00%	50.00%	102.60%	100.00%	114.64%	100.44%	102.14%	100.00%	101.09%	109.25%	109.25%	83.71%	120.29%	226.31%	53.65%	2526.26%	91.81%	71.40%	98.72%	99.34%	93.06%	97.44%	97.35%	108.74%	100.37%	86.42%	100.44%	101.98%	105.48%	102.42%	101.54%	100.76%	100.73%	100.00%
Dividend Paid to FCF	-	-	-	-	-1.27%	-	-	-	-	-5.69%	-3.85%	-15.70%	-23.17%	43.00%	-4.30%	-1.60%	10.57%	-0.68%	4.25%	2.55%	104.65%	80.11%	64.25%	64.99%	170.24%	-0.32%	0.00%	0.00%	-86.80%	-	-678.61%	-	-	-	-	-

Earnings

Report Date	Aug 3, 1994	Jan 9, 1997	May 19, 1997	Sep 12, 1997	Dec 31, 1998	Mar 31, 1999	Jun 30, 1999	Dec 31, 1999	Mar 31, 2000	Jun 30, 2000	Dec 31, 2000	Mar 31, 2001	Jun 30, 2001	Dec 31, 2001	Mar 31, 2002	Jun 30, 2002	Dec 31, 2002	Mar 31, 2003	Jun 30, 2003	Sep 30, 2003	Dec 31, 2003	Mar 31, 2004	Jun 30, 2004	Sep 30, 2004	Dec 31, 2004	Mar 31, 2005	Jun 30, 2005	Sep 30, 2005	Dec 31, 2005	Mar 31, 2006	Jun 30, 2006	Sep 30, 2006	Dec 31, 2006	Mar 31, 2007	Jun 30, 2007	Sep 30, 2007	Feb 13, 2008	May 14, 2008	Aug 12, 2008	Dec 1, 2008	Feb 10, 2009	May 8, 2009	Aug 7, 2009	Nov 30, 2009	Feb 8, 2010	May 7, 2010	Aug 6, 2010	Dec 3, 2010	Feb 4, 2011	May 6, 2011	Aug 5, 2011	Dec 2, 2011	Jan 31, 2012	May 1, 2012	Jul 31, 2012	Dec 4, 2012	Jan 30, 2013	May 2, 2013	Aug 1, 2013	Dec 3, 2013	Feb 3, 2014	May 1, 2014	Jul 31, 2014	Dec 2, 2014	Feb 3, 2015	Apr 30, 2015	Jul 30, 2015	Dec 1, 2015	Feb 2, 2016	Apr 28, 2016	Jul 28, 2016	Dec 12, 2016	Feb 9, 2017	May 9, 2017	Aug 8, 2017	Feb 14, 2018	May 9, 2018	Aug 14, 2018	Dec 13, 2018	Feb 13, 2019	May 15, 2019	Aug 8, 2019	Dec 12, 2019	Feb 12, 2020	May 13, 2020	Aug 13, 2020	Dec 9, 2020	Feb 10, 2021	May 12, 2021	Aug 12, 2021	Dec 2, 2021	Feb 9, 2022	May 12, 2022	Aug 11, 2022	Dec 5, 2022	Feb 9, 2023	May 11, 2023	Aug 10, 2023	Dec 8, 2023	Feb 14, 2024	Apr 1, 2024	Aug 8, 2024	Dec 5, 2024	Feb 13, 2025	May 8, 2025	Aug 12, 2025	Dec 1, 2025	Feb 11, 2026	May 13, 2026	Aug 10, 2026
EPS Estimate	-0.01	-0.28	-0.22	-0.21	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.41	0.44	0.58	-	0.14	0.07	0.41	-	1.07	0.90	0.99	0.14	0.50	0.36	0.31	0.02	0.80	0.47	-	-	0.07	-	-	-	-	-0.04	-0.80	-0.30	-0.50	-0.80	-0.08	-0.04	-0.60	-0.45	-0.05	-0.23	-0.33	-0.32	-0.04	-0.40	-0.30	-0.60	-0.09	-0.67	-1.15	-1.64	-0.30	-3.77	-3.30	-2.90	-2.35	-0.10	-1.50	-0.60	-0.08	-0.80	-0.50	-0.50	-0.06	-0.47	-0.28	-0.32
EPS Actual	-0.04	-0.63	-0.28	-0.11	-0.92	-1.07	-0.95	-1.09	-0.82	-0.68	-0.46	-0.30	0.01	-0.25	-0.01	-1.77	-0.27	-0.47	-0.13	-0.39	-0.33	-0.37	-0.03	-0.40	-0.55	0.02	-0.09	-0.06	0.03	0.02	-0.01	0.02	-0.09	0.11	0.11	0.43	0.28	0.41	0.18	0.83	0.57	0.70	0.23	0.82	-0.27	0.64	0.03	1.92	0.10	0.03	0.10	1.56	0.90	0.70	0.90	2.83	1.20	1.20	0.30	0.23	0.50	0.10	0.40	-0.02	0.30	0.60	0.04	0.02	0.05	0.00	0.02	-0.06	-0.04	-0.06	-0.30	-0.40	-0.70	-1.50	-0.14	-0.30	-0.60	-0.40	-0.05	-0.50	-0.10	-0.50	0.03	-0.20	-0.40	-0.30	-0.05	-0.80	-1.80	-2.80	-0.51	-4.60	-4.32	-1.24	-1.37	-0.08	-0.91	-0.76	-0.05	-0.71	-0.60	-0.53	0.09	-0.26	-0.13	-0.30
Surprise	-300.00%	-125.00%	-27.27%	47.62%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-75.61%	-93.66%	-82.76%	-	542.86%	900.00%	119.51%	-	12.15%	33.33%	-69.70%	64.29%	0.00%	-72.22%	29.03%	-200.00%	-62.50%	27.66%	-	-	-26.57%	-	-	-	-	-50.00%	62.50%	-33.33%	-40.00%	-87.50%	-75.00%	-650.00%	0.00%	11.11%	0.00%	-117.39%	69.70%	-56.25%	175.00%	50.00%	-33.33%	50.00%	44.44%	-19.40%	-56.52%	-70.73%	-70.00%	-22.02%	-30.91%	57.24%	41.70%	20.00%	39.33%	-26.67%	35.00%	11.25%	-20.00%	-6.00%	258.73%	44.68%	53.57%	6.25%
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap43.31M

Enterprise Value18.84M

Trailing P/E0.00

Forward P/E117.65

PEG Ratio3.60

Price / Sales3.11

Price / Book1.48

EPS-0.61

Book Value1.66

Revenue (TTM)16.89M

Gross Profit (TTM)5.85M

EBITDA-27.70M

Profit Margin0.00%

Operating Margin0.00%

Return on Equity-64.54%

Return on Assets-54.03%

Shares Outstanding17.05M

Shares Float15.48M

Beta-1.16

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Analyst Ratings

Buy

Based on 5 analystsTarget 24.50

Strong Buy
2
Buy
2
Hold
1

Ownership Breakdown

Institutions: 19.64%
Insiders: 9.22%
Retail / Other: 71.14%

Top Institutional Holders

Alyeska Investment Group, L.P.
1.00M5.87%
Vanguard Capital Management, LLC
539.38K3.16%
Oppenheimer & Co Inc
196.30K1.15%
Geode Capital Management, LLC
184.62K1.08%
GSA Capital Partners LLP
157.34K0.92%
Summit Financial LLC
141.87K0.83%
Ikarian Capital, LLC
133.52K0.78%
BlackRock Inc
114.17K0.67%
Vanguard Fiduciary Trust Co
80.65K0.47%
RSM US WEALTH MANAGEMENT LLC
74.81K0.44%
Goss Wealth Management LLC
70.33K0.41%
Renaissance Technologies Corp
69.25K0.41%
Citadel Advisors Llc
61.98K0.36%
Blair William & Co
58.00K0.34%
State Street Corp
55.00K0.32%
Algert Global LLC
42.14K0.25%
ADAR1 Capital Management LLC
35.00K0.21%

Top Fund Holders

Vanguard MStar Total Stk Mkt Idx Invest
531.94K3.12%
Fidelity Extended Market Index
74.39K0.44%
iShares Micro-Cap ETF
49.25K0.29%

Dividends

20142×

0.70Apr 28, 20140.70Jan 27, 2014

20134×

0.70Oct 28, 20130.70Jul 29, 20130.70Apr 29, 20130.60Jan 28, 2013

20125×

0.60Oct 31, 20120.06Oct 29, 20120.60Jul 30, 20120.60Apr 30, 20120.50Jan 30, 2012

20114×

0.50Oct 31, 20110.50Jul 29, 20110.50Apr 29, 20110.50Jan 27, 2011

20104×

0.50Nov 1, 20100.50Aug 2, 20100.50Apr 21, 20100.50Jan 27, 2010

Stock Splits

Aug 11, 20251:10